Indeed, CD70 genetic changes identified in our patient cohorts did not show any significant preference for the GCB or non‐GCB subtype; instead, they were enriched in HBV+ DLBCL patients. The gene discussed is CD70; the disease is diffuse large B-cell lymphoma.